A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

Although the majority of patients with nasopharyngeal carcinoma (NPC) present with early-stage or locoregional disease that can be treated with definitive radiotherapy, approximately 20% of patients experience disease recurrence, and 15% present with metastatic disease that is not amenable to curati...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anna Spreafico, Eric Winquist, Cheryl Ho, Brian O’Sullivan, Nathaniel Bouganim, Neil Chua, Sarah Doucette, Lillian L. Siu, Desiree Hao
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-01-01
Schriftenreihe:	Current Oncology
Schlagworte:	nasopharyngeal carcinoma head and neck cancer Epstein-Barr virus human papillomavirus immunotherapy
Online-Zugang:	https://www.mdpi.com/1718-7729/32/1/48
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!